Historic moment in 75years of NHS! 1st National Consultant Strike. Is not only for #FixConsultantPay it’s about protecting the future of the NHS consultant workforce. #fightforyourNHS The BMA

Join us for the #CTOS2023 Sunrise Mentorship ☕️Sessions in Dublin Nov 2&3 How to set up Clinical Trials, Giving Feedback to Starting your own Lab - great opportunity to network with #sarcoma experts!

Nice discussion this morning @CTOS2023 #mentorship sunrise session: global networking - virtual care and research. Thank you to all the attendees and Catherine Sarre Jason Sicklick Continue sharing ideas and collaborating 😊

Today, we approved the first drug for adult patients with progressing desmoid tumors who require systemic treatment. fda.gov/news-events/pr…

The DTRF hosted a Scientific and Medical Advisory Board Meeting on Friday, March 29th. We are grateful for the expertise and guidance this team of experts has provided the Foundation over the years. 🔗 dtrf.org/about-dtrf/adv…

Fresh off the press

This impressive collaborative effort is finally out - Current Management of Desmoid Tumors: A Review | Pediatric Cancer | JAMA Oncology | JAMA Network ⁦Desmoid Tumor Research Foundation⁩ ⁦Desmoid Foundation ONLUS - Italia⁩ ⁦⁦CTOS⁩ ⁦SPAGN⁩ jamanetwork.com/journals/jamao…

Afamicel, TCR targeting MAGEA-4 approved for #synovial sarcoma. A remarkable advancement for our patients, laying the foundation for future efforts in solid tumors. businesswire.com/news/home/2024…

oncodaily.com/insight/117698…

Dear colleagues and friends, as I am sure all of you know, my mentor, colleague, and friend Dr. Chris Fletcher passed away last month. Several of his friends are initiating a fundraising activity through the USCAP Foundation to support an annual award in his name at the USCAP

Lifetime Cancer Risk Associated with High- and Moderate-Penetrance Mutations in Selected Genes #hereditarycancer

Happy to share our latest work published in Annals of Oncology: 🚫 Lack of ctDNA clearance during neoadj IO may identify patients unlikely to achieve pCR. ⚠️ ctDNA clearance has limited confirmatory power due to low specificity and high heterogeneity. Thanks to all coauthors!

KS is still one of the most common cancers in the world. Phenomenal activity with abemaciclib. #ASCO25

⁦Vinod Ravi, MD⁩ with an excellent summary of decades of work looking at neoadjuvant/adjuvant chemo for #sarcoma . Still no consensus.

Honoring a legend: A beautiful tribute to Dr. Christopher Fletcher—visionary leader, world-renowned soft tissue pathologist, and mentor to many. Portrait by Dr. Christopher French. Thank you, Dr. French, for capturing the spirit of a true icon in pathology. 💫 #PathTwitter

🌟New opportunity for Trainees and Junior Faculty of CTOS! We are launching a new initiative - the Young Investigator Group (YIG)! ⬇️Check below the details and apply or share with your young colleagues! It's an opportunity that can not be missed! 📩 applications [email protected]

This is wonderful to hear! 🎉 Desmoid patients in Europe have been waiting a long time for this news ir.springworkstx.com/news-releases/…

#CTOS2025 is not only about great science, it's also a perfect opportunity for mentorship for trainees and young fellows! Don't miss the 🌅 Sunrise Mentorship Session on Nov 13, 7.00 am ( breakfast and coffee will be served ☕)! Check topics and mentors 🧑‍🏫on the graphic⬇️

Deepest condolences to his family. May his memory be a blessing and an inspiration for the next generations and for us all.